August 20, 2019 / 5:12 AM / a month ago

BRIEF-Kuros Biosciences H1 Net Loss At CHF 5.2 Million

Aug 20 (Reuters) - Kuros Biosciences AG:

* PRODUCT SALES WERE CHF 0.9 MILLION IN FIRST HALF OF 2019, A SUBSTANTIAL INCREASE COMPARED TO H1 2018

* OTHER INCOME IN FIRST HALF OF 2019 AND 2018 WAS CHF 0.2 MILLION AND CHF 1.1 MILLION RESPECTIVELY

* NET LOSS AS PER JUNE 30, 2019 AMOUNTS TO CHF 5.2 MILLION AND REMAINS UNCHANGED COMPARED TO CORRESPONDING PERIOD IN FIRST HALF OF 2018.

* EXPECTS A FURTHER ACCELERATION FOR REMAINDER OF 2019. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below